BayWa’s €300 Million Apple Bet Won’t Plug a €5.4 Billion Debt Hole

BayWa's €300M T&G stake sale barely dents €5.4B debt as banks weigh standstill extension; stock drops 18% amid restructuring risks.

The sale of a New Zealand apple marketer is meant to be a cornerstone of BayWa’s turnaround, but even if Goldman Sachs lands a buyer at the target price, the math remains brutal. The agricultural conglomerate is staring down roughly €5.4 billion in total debt, and the most critical decisions—whether its two lead banks will extend a standstill agreement through autumn 2026—are still weeks away.

Goldman Sachs has been shopping BayWa’s 74% stake in T&G Global since March 2026. The fruit trader, which sells Envy and Jazz apples across more than 60 countries, generated $1.3 billion in revenue in 2024 and swung back to a net profit of $16 million. That profitability makes the disposal a strategic pruning rather than a fire sale, but the process has stalled. A minority shareholder based in Hong Kong, holding roughly a fifth of the equity, is dragging out negotiations. T&G Global itself confirmed the Goldman mandate but stressed no sale decision has been made.

BayWa is targeting proceeds of around €300 million from the T&G exit. Private equity firms Roc Partners and Paine Schwartz are among the potential bidders. Yet that sum barely dents the broader picture. The company needs to deleverage by €4 billion by 2028. Previous transactions, including the sale of Dutch subsidiary Cefetra, have secured liability reductions of €1.3 billion. The missing piece was a planned partial sale of the renewables arm BayWa r.e., which could have fetched up to €1.7 billion—until the US scrapped clean-energy subsidies in early 2025, killing the deal.

Investors have taken note. The stock has shed roughly 18% since the start of the year, trading at €13.75, well below its 200-day moving average of €16.67. The annualized volatility has topped 50%, making the equity a high-stakes bet.

The entire restructuring plan rests on a knife-edge. DZ Bank and HVB must approve an extension of the standstill agreement until autumn 2026. Without their green light, the StaRUG plan finalized last May loses its legal footing. A €107 million cash injection from the Cefetra sale arrived on April 30, giving management some negotiating leverage, but it does little to close the gap. Bavarian cooperative banks have already written off 60% of a promissory note loan; in a worst-case scenario, they face a total loss.

On the operational front, BayWa has scrapped its 2026 guidance. The EBITDA target for 2027 stands at roughly €140 million. By 2028, the group aims to shrink from a €24 billion conglomerate to a focused agricultural and building-materials trader with around €10 billion in revenue—a process that will eliminate roughly 1,300 jobs.

Legal risks are mounting. The Tübingen law firm TILP is preparing damages claims on behalf of shareholders, alleging that BayWa misled the market about material facts between January 2022 and January 2026. The case is based on a reprimand from financial regulator BaFin, which found that the 2023 management report omitted key refinancing risks. Auditor PwC is also in the spotlight for issuing an unqualified audit opinion for 2023 without flagging existential threats. All parties are presumed innocent.

Governance is being overhauled. Three capital-side supervisory board seats are being refilled after Michael Höllerer, Monika Hohlmeier, and Monique Surges resigned. From 2028, a rotating election system will apply, with shorter four-year terms replacing the previous five-year cycle. The threshold for board-approval of management transactions has already been lowered.

A reliable financial picture remains elusive. The audited 2025 consolidated accounts are not expected until the fourth quarter of 2026. The first-quarter report, due May 6, will offer clues on whether cost-cutting is gaining traction, but until the banks decide and the audited numbers land, BayWa’s stock remains a speculative play on a restructuring that is far from complete.